Posted in | News | Gold | Mining Business

GeoNovus Completes Due Diligence to Acquire Redhill’s Interest in Nyakagwe Project

GEONOVUS MINERALS CORP. ("GeoNovus" or the "Company") has announced that it has completed its due diligence with respect to its proposed option to acquire all of Redhill Resources Corp. ("Redhill")'s interest to the Nyakagwe Project in Tanzania (the "Nyakagwe Project"), which was previously announced in the Company's news release dated September 25, 2012. The Company intends to proceed in settling the terms of the acquisition with Redhill in a formal option agreement.

The Nyakagwe Project consists of Tanzanian primary mining licenses and a prospecting license which together encompass a combined area of approximately 500 hectares surrounded entirely by prospecting licenses and applications for prospecting licenses owned and presently explored by Tembo Gold Corp.

Further information regarding the deal terms and the Nyakagwe Project can be found in the Company's news release dated September 25, 2012.

GeoNovus Minerals Corp. is a junior exploration company actively seeking mineral and energy development opportunities for the benefit of all of its stakeholders, with three active porphyry copper exploration projects in Arizona.

GeoNovus Minerals Corporation (TSX VENTURE:GNM) is a junior exploration company actively seeking mineral and energy development opportunities for the benefit of all our stakeholders, with three active porphyry copper exploration projects in Arizona.

ON BEHALF OF THE BOARD

Michael England, President

Source: http://www.geonovusminerals.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.